Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
NCT ID: NCT01159613
Last Updated: 2010-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2008-04-30
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anticipated and Perceived Benefits Following Hepatitis C Treatment
NCT03000023
Hepatitis C Treatment and Atherosclerosis
NCT00659256
Transforming the Cascade Of Hepatitis C Care
NCT03226509
Hepatitis C Translating Initiatives for Depression Into Effective Solutions
NCT01143896
The Effect of Antiviral Therapy With Pegylated Interferon-alpha on Auditory Disability
NCT01265693
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim: to assess the association between lipids components of the metabolic syndrome and sustained viral response (SVR).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non Responders
Non Responders
Non Responders
Non Responders
RESPONDERS
Responders
Responders
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Responders
Responders
Non Responders
Non Responders
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Decompensated liver disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziv Hospital
OTHER_GOV
Hillel Yafe MC Hadera
UNKNOWN
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ziv medical center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ziv medical center liver unit
Safed, Israel, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HDL + HCV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.